Disease | pulmonary hypertension |
Phenotype | C0024141|systemic lupus erythematosus |
Sentences | 12 |
PubMedID- 22983159 | To develop a more comprehensive understanding of the clinical and pathological characteristics of pulmonary hypertension associated with systemic lupus erythematosus (ph/sle) in the chinese population, a systematic review of the literature up to 2012 was conducted. |
PubMedID- 24599923 | pulmonary hypertension in systemic lupus erythematosus: echocardiography-based definitions predict 6-year survival. |
PubMedID- 24428867 | High levels of uric acid in systemic lupus erythematosus is associated with pulmonary hypertension. |
PubMedID- 24263143 | pulmonary hypertension in systemic lupus erythematosus: pulmonary thromboembolism is the leading cause. |
PubMedID- 22841984 | pulmonary hypertension in systemic lupus erythematosus: prevalence, predictors and diagnostic strategy. |
PubMedID- 24238697 | pulmonary hypertension in systemic lupus erythematosus. |
PubMedID- 25750566 | pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival. |
PubMedID- 21597395 | Objective: to detect coronary artery disease in asymptomatic patients with systemic lupus erythematosus and scleroderma associated with pulmonary hypertension, and to determine whether it is focal or diffuse ischemia. |
PubMedID- 25119257 | A 42-year-old woman was admitted due to systemic lupus erythematosus complicated with glomerulonephritis and pulmonary hypertension. |
PubMedID- 23780636 | Primary and secondary pulmonary hypertension in systemic lupus erythematosus. |
PubMedID- 22084605 | Asymptomatic pulmonary hypertension in systemic lupus erythematosus. |
PubMedID- 20012052 | pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome. |
Page: 1